SPRING BK PHARMACEUTICALS IN - COM (SBPH)

CUSIP: 849431101

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
3,584,166
Share change
+2,379,853
Total reported value
$48,530,000
Price per share
$13.54
Number of holders
32
Value change
+$32,638,609
Number of buys
27
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 849431101?
CUSIP 849431101 identifies SBPH - SPRING BK PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPRING BK PHARMACEUTICALS IN - COM (SBPH) as of Q2 2017

As of 30 Jun 2017, SPRING BK PHARMACEUTICALS IN - COM (SBPH) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,584,166 shares. The largest 10 holders included BVF INC/IL, Alyeska Investment Group, L.P., BAKER BROS. ADVISORS LP, TIEDEMANN WEALTH MANAGEMENT, LLC, PARSONS CAPITAL MANAGEMENT INC/RI, RTW INVESTMENTS, LP, AXA, SPHERA FUNDS MANAGEMENT LTD., Sectoral Asset Management Inc, and Monashee Investment Management LLC. This page lists 32 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.